Johnson & Johnson COVID-19 vaccine boxes are seen at a vaccination site. Doses of the Johnson & Johnson vaccine are being administered throughout the state of Florida despite a small number of patients who have experienced adverse reactions, including blood clots. (Photo by Paul Hennessy / SOPA Images/Sipa USA)
Johnson & Johnson Covid-19 vaccine paused
(AP) — Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.
The health care giant said Tuesday that a supply surplus and demand uncertainty prompted the move. J&J’s one-shot vaccine brought in $457 million in global sales during the first quarter, with most of that coming from outside the United States.
The vaccine brought in only $75 million in U.S. sales. That’s less than what it rang up after debuting in last year’s quarter.
—Copyright 2022 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
